This Article 
   
 Share 
   
 Bibliographic References 
   
 Add to: 
 
Digg
Furl
Spurl
Blink
Simpy
Google
Del.icio.us
Y!MyWeb
 
 Search 
   
A Causal Probabilistic Network for Optimal Treatment of Bacterial Infections
July/August 2000 (vol. 12 no. 4)
pp. 517-528

Abstract—The fatality rate associated with severe bacterial infections is about 30 percent and appropriate antibiotic treatment reduces it by half. Unfortunately, about a third of antibiotic treatments prescribed by physicians are inappropriate. We have built a causal probabilistic network (CPN) for treatment of severe bacterial infections. The net is based on modules, each module representing a site of infection. The general configuration of a module is as follows: Major distribution factors define groups of patients, each of them with a definite prevalence of infection caused by a given pathogen. Minor distribution factors multiply the likelihood of one pathogen, without changing much of the prevalence of infection. Infection caused by a pathogen causes local and generalized signs and symptoms. Antibiotic treatment is appropriate if it matches the susceptibility of the pathogens in vitro and appropriate treatment is associated with a gain in life expectancy. This is balanced against the cost of the drug, side effects, and ecological damage, to reach the most cost effective treatment. The net was constructed in such a way that the data for the conditional probability tables will be available, even if it meant sometimes giving up on fine modeling details. For data, we used large databases collected by us in the last 10 years and data from the literature. The CPN was a convenient way to combine data from databases collected at different locations and times with published information. Although the net is based on detailed and large databases, its calibration to new sites requires data that is available in most modern hospitals.

[1] C.S. Bryan, K.L. Reynolds, and E.R. Brenner, “Analysis of 1,186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial Therapy,” Rev. of Infectious Diseases, vol. 5, pp. 629–638, 1983.
[2] M.P. Weinstein, J.R. Murphy, L.B. Reller, and K.A. Lichtenstein, “The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungaemia in Adults II. Clinical Observations, with Special Reference to Factors Influencing Prognosis,” Rev. of Infectious Diseases, vol. 5, pp. 54–70, 1983.
[3] P. Ispahani, N.J. Pearson, and D. Greenwood, “An Analysis of Community and Hospital-Acquired Bacteraemia in a Large Teaching Hospital in the United Kingdom,” Quarterly J. Medicine, vol. 63, pp. 427–440, 1987.
[4] J.B. Haug, S. Harthug, T. Kalager, A. Digranes, and C.O. Solberg, “Bloodstream Infections at a Norwegian University Hospital, 1974–1979 and 1988–1989: Changing Etiology, Clinical Features and Outcome,” Clinical Infectious Diseases, vol. 19, pp. 246–56, 1994.
[5] D. Pittet and R.P. Wenzel, “Nosocomial Bloodstream Infections: Secular Trends in Rates, Mortality, and Contribution to Total Hospital Deaths,” Archives of Internal Medicine, vol. 155, pp. 1,177–1,184, 1995.
[6] L. Leibovici, Z. Samra, H. Konigsberger, M. Drucker, S. Ashkenazi, and S.D. Pitlik, “Long-Term Survival Following Bacteremia or Fungemia,” J. Am. Medical Assoc., vol. 274, pp. 807–812, 1995.
[7] G.R. Jones and J.A. Lowes, “The Systemic Inflammatory Response Syndrome as Predictor of Bacteraemia and Outcome from Sepsis,” Quarterly J. Medicine, vol. 89, pp. 515–522, 1996.
[8] G. Pedersen, H.C. Schønheyder, and H.T. Sørensen, “Antibiotic Therapy and Outcome of Monomicrobial Gram-Negative Bacteraemia: A 3-year Population Based Study,” Scandinavian J. Infectious Diseases, vol. 29 pp. 601–606, 1997.
[9] R.C. Bone, “Toward a Theory Regarding the Pathogenesis of the Systemic Inflammatory Response Syndrome: What We Do and Do Not Know about Cytokine Regulation,” Critical Care Medicine, vol. 24 pp. 163–172, 1996.
[10] L. Leibovici, V. Gitelman, Y. Yehezkelli, O. Poznanski, G. Milo, M. Paul, and P. Ein-Dor, “Improving Empirical Antibiotic Treatment: Prospective, Nonintervention Testing of a Decision Support System,” J. Internal Medicine, vol. 242, pp. 395–400, 1997.
[11] L. Leibovici, H. Konigsbereger, S.D. Pitlik, Z. Samra, and M. Drucker, “A Predictive Index Optimizing Empiric Treatment of Gram-Negative Bacteremia,” J. Infectious Diseases, vol. 163, pp. 193–196, 1991.
[12] L. Leibovici, H. Konigsberger, S.D. Pitlik, Z. Samra, and M. Drucker, “Patients at Risk for Inappropriate Antibiotic Treatment of Bacteremia,” J. Internal Medicine, vol. 231, pp. 371–374, 1992.
[13] D.G. Maki and A.A. Schune, “A Study of Antibiotic Misuse in a University Hospital,” Am. J. Medical Sciences, vol. 275, pp. 271–82, 1978.
[14] J.R. Berman, F.K. Zaran, and M.J. Rybak, “Pharmacy-Based Antimicrobial Monitoring Service,” Am. J. Hospital Pharmacy, vol. 49, pp. 1,701–1706, 1992.
[15] A. Tomasz, “Multiple Antibiotic Resistant Pathogenic Bacteria,” New England J. Medicine, vol. 330, pp. 1,247–1,251, 1994.
[16] J.G. Morris, D.K. Shay, J.N. Hebden, R.J. McCarter, B.E. Perdue, W. Jarvis, J.A. Johnson, T.C. Dowling, L.B. Polish, and R.S. Schwalbe, “Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical Center,” Annals of Internal Medicine, vol. 123, pp. 250–259, 1995.
[17] E.S. Go, C. Urban, J. Burns, B. Kreiswirth, W. Eisner, N. Mariano, K. Mosinka-Snipas, and J.J. Rahal, “Clinical and Molecular Epidemiology of Acinetobacter Infections Sensitive Only to Polymyxin B and Sulbactam,” Lancet, vol. 344 pp. 1,329–1,332, 1994.
[18] S.L. Pestotnik, D.C. Classen, R.S. Evans, and J.P. Burke, “Implementing Antibiotic Practice Guidelines through Computer-Assisted Decision Support: Clinical and Financial Outcomes,” Annals of Internal Medicine, vol. 124, pp. 884–890, 1996.
[19] R.S. Evans, D.C. Classen, S.L. Pestotnik, H.P. Lundsgaarde, and J.P. Burke, “Improving Empiric Antibiotic Selection Using Computer Decision Support,” Archives of Internal Medicine, vol. 154, pp. 878–884, 1994.
[20] S. Andreassen, L. Leibovici, H.C. Schoenheyder, K.G. Olesen, and B. Kristensen, “Decision Support Systems in Bacteremia: Evaluation of a Prototype for Empirical Treatment of Danish Patients with Urosepsis,” Proc. Bi-Nat'l Israel-Denmark Symp. Optimal Antibiotic Treatment of Severe Bacterial Infections: The Real Issues, Nov. 1996.
[21] D.J. Spiegelhalter, “Probabilistic Expert Systems in Medicine,” Statistical Science, vol. 2, pp. 3–44, 1987.
[22] S. Andreassen, “Planning of Therapy and Tests in Causal Probabilistic Networks,” Artificial Intelligence in Medicine, pp. 227–241, 1992.
[23] R. Montironi, W.F. Whimster, Y. Collan, P.W. Hamilton, D. Thompson, and P.H. Bartels, “How to Develop and Use a Bayesian Belief Network,” Clinical Pathology, vol. 49, pp. 194–201, 1996.
[24] D.E. Hechermann, B. Horvitz, and E. Nathwan, “Toward Normative Expert Systems: Part I. The Pathfinder Project,” Information in Medicine, vol. 31, pp. 90–105, 1992.
[25] S. Andreassen, F.V. Jensen, S.K. Andersen, B. Falck, U. Kjaerulff, M. Woldbye, A. Sørensen, A. Rosenfalck, and F. Jensen, “MUNIN: An Expert EMG Assistant,” Computer-aided Electromyography and Expert Systems, J.E. Desmedt, ed., Elsevier Science, pp. 255–277, 1989.
[26] S. Andreassen, J.J. Benn, R. Hoverka, K.G. Olesen, and E.R. Carson, “A Probabilistic Approach to Glucose Prediction and Insulin Dose Adjustment: Description of a Metabolic Model and Pilot Evaluation Study,” Computional Methods of Programming in Biomedicine, pp. 153–165, 1994.
[27] L. Leibovici, G. Alpert, O. Kalter-Leibovici, and Y.L. Danon, “A Clinical Model for Diagnosis of Bacterial Urinary Tract Infection in Young Women,” Archives of Internal Medicine, vol. 149, pp. 2,048–2,050, 1989.
[28] R. Arav-Boger, L. Leibovici, and Y.L. Danon, “Urinary Tract Infections with Low and High Colony Counts in Young Women: Spontaneous Remission and Single-Dose vs. Multiple Day Treatment,” Archives of Internal Medicine, vol. 154, pp. 300–304, 1994.
[29] L. Leibovici, S. Greeshtain, O. Cohen, and A.J. Wysenbeek, “Toward Improved Empiric Treatment of Moderate to Severe Urinary Tract Infection,” Archives of Internal Medicine, vol. 152, pp. 2,481–2,486, 1992.
[30] C.M. Kunin, Urinary Tract Infections: Detection, Prevention, and Management, fifth ed., p. 5. Baltimore: Williams&Wilkins, 1996.
[31] B.A. Lipsky, “Urinary Tract Infections in Men: Epidemiology, Pathophysiology, Diagnosis and Treatment,” Annals of Internal Medicine, vol. 110, pp. 138–150, 1989.
[32] C.M. Kunin, “Urinary Tract Infections in Females,” Clinical Infectious Diseases, vol. 18, pp. 1–12, 1994.
[33] D. Kaye, “Urinary Tract Infections in the Elderly,” Bulletin New York Academy of Medicine, vol. 56, pp. 209–217, 1980.
[34] J.A. Boscia, W.D. Kobasa, E. Abrutyn, M.E. Levison, A.M. Kaplan, and D. Kaye, “Lack of Association Between Bacteriuria and Symptoms in the Elderly,” Am. J. Medicine, vol. 81, pp. 979–982, 1986.
[35] G.L. Mandell and J.E. Bennet, Principles and Practice of Infectious Diseases, fourth ed., R. Dolin, ed., pp. 662–690. New York: Churchill Livingstone, 1996.
[36] J.A. Boscia, W.D. Kobasa, R.A. Knight, E. Abrutyn, M.E. Levison, and D. Kaye, “Epidemiology of Bacteriuria in an Elderly Ambulatory Population,” Am. J. Medicine, vol. 80, pp. 208–214, 1986.
[37] D. Grahn, D.C. Norman, M.L. White, M. Cantrell, and T.T. Yoshikawa, “Validity of Urinary Catheter Specimen for Diagnosis of Urinary Tract Infection in the Elderly,” Archives of Internal Medicine, vol. 145, pp. 1,858-1,860, 1985.
[38] U. Setia, I. Serventi, and P. Lorenz, “Nososcomial Infections Among Patients in a Long-Term Care Facility: Spectrum, Prevalence, and Risk Factors,” Am. J. Infection Control, vol. 13, pp. 57–62, 1985.
[39] J.W. Warren, D. Damron, J.H. Tenney, J.M. Hoopes, B. Deforge, and H.L. Muncie, “Fever, Bacteremia, and Death as Complications of Bacteriuria in Women with Long-Term Urethral Catheters,” J. Infectious Diseases, vol. 155, pp. 1,151–1,154, 1987.
[40] J. Magaziner, J.H. Tenney, B. Deforge, J.R. Hebel, H.L. Muncie, and J.W. Warren, “Prevalence and Characteristics of Nursing Home Acquired Infections in the Aged,” J. Am. Geriatriac Soc., vol. 39, pp. 1,071–1,078, 1991.
[41] T. Bregenzer, R. Frei, A.F. Widmer, W. Seiler, W. Probst, G. Mattarelli, and W. Zimmerli, “Low Risk of Bacteremia during Catheter Replacement in Patients with Long-Term Urinary Catheters,” Archives of Internal Medicine, vol. 157, pp. 521–525, 1997.
[42] L.E. Nicolle, J. Bjornson, G.K.M. Harding, and J.A. MacDonnel, “Bacteriuria in Elderly Institutionalized Men,” New England J. Medicine, vol. 309, pp. 1,420–1,425, 1983.
[43] C.M. Kunin, Q.F. Chin, and S. Chambers, “Indwelling Urinary Catheters in the Elderly: Relaton of‘Catheter Life’to Formation of Encrustations in Patients with and without Blocked Cathaters,” Am. J. Medicine, vol. 82, pp. 405–409, 1987.
[44] R.B. Breitenbucher, “Bacterial Changes in the Urine Samples of Patients with Long-Term Indwelling Catheters,” Archives of Internal Medicine, vol. 144, pp. 1,585–1,588, 1984.
[45] L.E. Nicolle, W.J. Mayhew, and L. Bryan, “Prospective Randomized Comparison of Therapy and No Therapy for Asymptomatic Bacteriuria in Institutionalized Elderly Women,” Am. J. Medicine, vol. 83, pp. 27–31, 1987.
[46] V. Tzias, A.S. Dontas, G. Petrikkos, M. Papapetropoulou, J. Dracopoulos, H. Giamarellou, “Three Day Antibiotic Therapy in Bacteriuria of Old Age.,” J. Antimicrobial Chemotherapy, vol. 26, pp. 705–711, 1990.
[47] J.G. Ouslander, B. Greengold, and S. Chen, “Complications of Chronic Indwelling Urinary Catheters among Male Nursing Home Patients: A Prospective Study,” J. Urology, vol. 138, pp. 1,191–1,195, 1987.
[48] R. Gleckman, N. Blagg, D. Hibert, A. Hall, M. Crowley, A. Pritchard, and W. Warren, “Catheter-Related Urosepsis in the Elderly: A Prospective Study of Community-Derived Infections,” J. Am. Geriatriacs, vol. 30, pp. 255–257, 1982.
[49] C.M. Kunin, Urinary Tract Infections: Detection, Prevention, and Management, fifth ed., pp 241–244. Baltimore: Williams&Wilkins, 1996.
[50] D.E. Craven, L.M. Kunches, D.A. Lichtenberg, N.R. Kollisch, A. Barry, T.C. Heeren, and W.R. McCabe, “Nosocomial Infection and Fatality in Medical and Surgical Intensive Care Unit Patients,” Archives of Internal Medicine, vol. 148, pp. 1,161–1,168, 1988.
[51] J.-L. Vincent, D.J. Bihari, P.M. Suter, H.A. Bruining, J. White, M.-H. Chanoin, M. Wolff, R.C. Spencer, and M. Hemmer, “The Prevalence of Nosocomial Infection in Intensive Care Units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study,” J. Am. Medical Assoc., vol. 274, pp. 639–644, 1995.
[52] W.R. Gransden, L. Leibovici, S.J. Eykyn, S.D. Pitlik, Z. Samra, H. Konigsberger, M. Drucker, and I. Phillips, “Risk Factors and a Clinical Index for Diagnosis of Pseudomonas Aeruginosa Bacteremia,” J. Clinical Microbiology Infection, vol. 1, pp. 119–123, 1996.
[53] A nonymous. “Hospitals, Nursing Homes and Day Care Units in Israel: Statistical Data by Institution and Department,” Health Ministry, Computing and Information Service (Hebrew), 1996.
[54] A nonymous. Ann. Statistical Report, vol. 48, The Central Office for Statistics (Hebrew), 1997.
[55] J. Kohler-Ockmore and R.C. Feneley, “Long Term Catheterization of the Bladder: Prevalence and Morbidity,” British J. Urology, vol. 77, pp. 347–51, 1996.
[56] D.J. Hunter, A. Berra-Unamuno, and A. Martin-Gordo, “Prevalence of Urinary Symptoms and Other Urological Conditions in Spanish Men 50 Years Old or Older,” J. Urology, vol. 155, pp. 1,965–1,970, 1996.
[57] D. Rothenbacher, G. Bode, G. Adler, and H. Brenner, “Use of Commonly Prescribed Antibiotics Is Not Associated with Prevalence of Helicobacter Pylori Infections in Adults,” Scandinavian J. Gastroenterology, vol. 32, pp. 1,069–1,090, 1997.
[58] D. Guillemot, C. Carbon, F. Vauzelle-Kervroedan, B. Balkau, P. Maison, G. Bouvenot, and E. Eschwege, “Inappropriateness and Variability of Antibiotic Prescription among French Office-Based Physicians,” J. Clinical Epidemiology, vol. 51, pp. 61–68, 1998.
[59] C.M. Kunin, L. White VanArsdale, and T.H. Hua, “A Reassessment of the Importance of‘Low-Count’Bacteriuria in Young Women with Acute Urinary Symptoms,” Annals of Internal Medicine, vol. 119, pp. 454–460, 1993.
[60] L. Leibovici, R. Arav-Boger, and Y.L. Danon, “A Clinical Model for Diagnosis of Urinary Tract Infection in Young Women,” Archives of Internal Medicine, vol. 153, pp. 1,011–1,015, 1993.
[61] H.L. Corwin and M.D. Silverstein, “Microscopic Hematuria,” Clinical Laboratory Medicine, vol. 8, pp. 601–610, 1988.
[62] M. Laville, P. Roy, H. Pellet, J. Fabry, and P. Zech, “Microscopic Hematuria in Adults: Prevalence and Associated Factors,” Presse Medicine, vol. 20, pp. 545–50, 1991 (in French).
[63] M. Korpela, J. Mustonen, A. Heikkinen, H. Helin, and A. Pasternack, “Isolated Microscopic Hematuria in Patients with Rheumatoid Arthritis Compared with Age and Sex Matched Controls. A Population Based Study,” J. Rheumatology, vol. 22, pp. 427–431, 1995.
[64] G.G. Wolfs, J.A. Knottnerus, and R.A. Jangtnegt, “Prevalence and Detection of Micturition Problems among 2,734 Elderly Men,” J. Urololgy, vol. 152, pp. 1,467–1,470, 1994.
[65] S. Woolhandler, R.J. Pels, D.H. Bor, D.U. Himmelstein, and R.S. Lawrence, “Dipstick Urinalysis Screening of Asymptomatic Adults for Urinary Tract Disorders. I. Hematuria and Proteinuria,” J. Am. Medical Assoc., vol. 262, pp. 1,214–1,219, 1989.
[66] P. Froom, J. Ribak, and J. Benbassat, “Significance of Microhematuria in Young Adults,” British Medical J., vol. 288, pp. 20–22, 1984.
[67] N. Alwall and A. Lohi, “A Population Study on Renal and Urinary Tract Disease,” Acta Medica Scandinavica, vol. 194, pp. 529–535, 1973.
[68] E.M. Messing, T.B. Young, V.B. Hunt, S.E. Emoto, and J.M. Webbie, “The Significance of Asymptomatic Microhematuria in Men 50 or More Years Old: Findings of a Home Screening Study Using Urinary Dipsticks,” J. Urology, vol. 137, pp. 919–922, 1987.
[69] H. Eriksson, K. Svardsudd, B. Larsson, L. Welin, L.-O. Ohlson, and L. Wilhemsen, “Body Temperature in General Population Samples,” Acta Medica Scandinavica, vol. 217, pp. 347–352, 1985.
[70] J.R. Eskerud, E. Laerum, H. Fagerthun, P.K.M. Lunde, and A.A. Naes, “Fever in General Practice. I. Frequency and Diagnoses,” Family Practice, vol. 9, pp. 263–279, 1992.
[71] M.-C. Corti, J.M. Guralnik, M.E. Salive, and J.D. Sorkin, “Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Patients,” J. Am. Medical Assoc., vol. 272, pp. 1,036–1,042, 1994.
[72] R.F. Gillum, D.D. Ingram, and D.M. Makuc, “White Blood Cell Count, Coronary Heart Disease, and Death: The NHANES I Epidemiologic Follow-Up Study,” Am. Heart J., vol. 125, pp. 855–863, 1993.
[73] P. Wetteland, M. Røger, H.E. Solberg, and O.H. Iversen, “Population-Based Erythrocyte Sedimentation Rates in 3,910 Subjectively Healthy Norwegian Adults: A Statistical Study Based on Men and Women from the Oslo Area,” J. Internal Medicine, vol. 240, pp. 125–131, 1996.
[74] F. Carlstedt, L. Lind, and B. Lindahl, “Proinflammatory Cytokines, Measured in a Mixed Population on Arrival in the Emergency Department, Are Related to Mortality and Severity of Disease,” J. Internal Medicine, vol. 242, pp. 361–365, 1997.
[75] C.M. Kunin and J.E. DeGroot, “Self-Screening for Significant Bacteriuria: Evaluation of Dipstrip Combination Nitrite/Culture Test,” J. Am. Medical Assoc., pp. 1,349–1,353, 1975.
[76] M.A. Pfaller and F.P. Koontz, “Laboratory Evaluation of Leukocyte Esterase and Nitrite Test for the Detection of Bacteriuria,” J. Clinical Microbiology, vol. 21, pp. 840–842, 1985.
[77] O.R. Madsen, M. Faber, L. Phillipsen, and N. Frimodt-Møller, “Demonstration of Bacteriuria in Elderly Hospitalized Patients: Comparison between Leukocyte and Nitrite Strip Tests and Culture,” Ugeskr Laeger, vol. 154, pp. 3,682–3,686, 1992 (in Danish).
[78] L. Leibovici, I. Shraga, M. Drucker, H. Konigsberger, Z. Samra, and S.D. Pitlik, “The Benefit of Appropriate Empirical Antibiotic Treatment in Patients with Bloodstream Infection,” J. Internal Medicine, vol. 244, pp. 379–386, 1998.
[79] R.B. Cattell, The Scientific Use of Factor Analysis. New York: Plenum, 1978.
[80] D. Spiegelhalter and S.L. Lauritzen, “Sequential Updating of Conditional Probabilities on Directed Graphical Structures,” Networks, vol. 20, pp. 579–605, 1990.
[81] D. Heckermann, “Bayesian Networks for Data Mining,” Data Mining and Knowledge Discovery, vol. 1, pp. 79–119, 1997.
[82] R.A. Howard and J.E. Matheson, “Influence Diagrams,” Readings on the Principles and Applications of Decision Analysis, R.A. Howard and J.E. Matheson, eds., vol. 2, pp. 719–762. Menlo Park, Cailf.: Strategic Decision Group, 1984.
[83] V. Hasselblad and D.C. McCrory, “Meta-Analytic Tools for Medical Decision Making: A Practical Guide,” Medical Decision Making, vol. 15, pp. 81–96, 1995.

Index Terms:
Causal probabilistic networks, bacterial infections, bacteremia, antibiotic treatment, cost-effectiveness.
Citation:
Leonard Leibovici, Michal Fishman, Henrik C. Schønheyder, Christian Riekehr, Brian Kristensen, Ilana Shraga, Steen Andreassen, "A Causal Probabilistic Network for Optimal Treatment of Bacterial Infections," IEEE Transactions on Knowledge and Data Engineering, vol. 12, no. 4, pp. 517-528, July-Aug. 2000, doi:10.1109/69.868905
Usage of this product signifies your acceptance of the Terms of Use.